Showing results (111-120 of 1,227) with videos related to

Sort By:
Pageof 123
Cancer Treatment and Research Communications|January 22, 2022
Eponyms in medical oncologyPriyanka Kumar, Danielle Brazel, David J Benjamin, et al.
Cancer Treatment and Research Communications|January 22, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?Valentina Ghirardi, Francesca De Felice, Marco D'Indinosante, et al.
Cancer Treatment and Research Communications|September 13, 2018
Benefit of crizotinib in a lung cancer patient with discordant ALK testing resultsSteven Grocholski, Shantanu Banerji, Gefei Qing, et al.
Cancer Treatment and Research Communications|May 11, 2019
ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase-positive non-small cell lung Cancer: A clinical perspectiveSalman Otoukesh, Tiffany Sanchez, Saied Mirshahidi, et al.
Cancer Treatment and Research Communications|July 8, 2019
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancerRohan Gupta, Mihaela Cristea, Paul Frankel, et al.
Cancer Treatment and Research Communications|March 1, 2022
Clinico-pathological predictors of clinical complete response in rectal cancerP Mbanu, E Vasquez Osorio, H Mistry, et al.
Cancer Treatment and Research Communications|March 7, 2022
New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathyJoanna E Szpejewska, Mette Yilmaz, Ursula G Falkmer, et al.
Cancer Treatment and Research Communications|July 1, 2019
Expression of micrornas in molecular genetic breast cancer subtypesN N Kolesnikov, Yu A Veryaskina, S E Titov, et al.
Cancer Treatment and Research Communications|April 6, 2023
Prognostic significance of CDK6 amplification in esophageal squamous cell carcinomaKun Liu, Huadong Lu, Dongxian Jiang, et al.
Cancer Treatment and Research Communications|April 21, 2021
Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinomaSimone Marcone, Amy Buckley, Colm J Ryan, et al.
Pageof 123